Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation.

Metzelder, S K

Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation. [electronic resource] - European journal of cancer (Oxford, England : 1990) 11 2017 - 233-239 p. digital

Publication Type: Journal Article; Multicenter Study; Observational Study

1879-0852

10.1016/j.ejca.2017.09.016 doi


Adolescent
Adult
Aged
Antineoplastic Agents--adverse effects
Biomarkers, Tumor--genetics
Disease Progression
Disease-Free Survival
Female
Germany
Humans
Kaplan-Meier Estimate
Leukemia, Myeloid, Acute--enzymology
Male
Middle Aged
Niacinamide--adverse effects
Phenylurea Compounds--adverse effects
Protein Kinase Inhibitors--adverse effects
Recurrence
Remission Induction
Retrospective Studies
Risk Factors
Sorafenib
Stem Cell Transplantation--adverse effects
Tandem Repeat Sequences
Time Factors
Transplantation, Homologous
Treatment Outcome
Young Adult
fms-Like Tyrosine Kinase 3--genetics